Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Beecham Group plc, 980 Great West Road, Brentford, Middlesex TW8 9GS Trading as: GlaxoSmithKline UK
Bactroban 2% cream.
| Pharmaceutical Form |
|---|
|
Cream. Bactroban Cream is presented as a white cream of homogeneous appearance. |
Each gram of cream contains: 21.5 mg Mupirocin calcium equivalent to 20.0 mg mupirocin.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Mupirocin |
Mupirocin is a novel antibiotic produced through fermentation by Pseudomonas fluorescens. Mupirocin inhibits isoleucyl transfer-RNA synthetase, thereby arresting bacterial protein synthesis. Mupirocin has bacteriostatic properties at minimum inhibitory concentrations and bactericidal properties at the higher concentrations reached when applied locally. |
| List of Excipients |
|---|
|
Xanthan gum |
Squeezable aluminium tubes with a screw cap containing 15 g of white cream.
Beecham Group plc, 980 Great West Road, Brentford, Middlesex TW8 9GS
Trading as: GlaxoSmithKline UK
PL 00038/0372
28 October 1998
| Drug | Countries | |
|---|---|---|
| BACTROBAN | Austria, Australia, Brazil, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Malta, Mexico, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
